DARCY WHITE: Open Payments
NPI 1184233462 · EL RENO, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 22 payments from 11 companies in 2025. Trend: 2023 $124 · 2024 $216 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Amgen Inc. | 3 | $44 |
| Astellas Pharma US Inc | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: VRAYLAR, BREZTRI, FANAPT, OTEZLA, Veozah, CAPLYTA, VOQUEZNA, JARDIANCE.
Industry payments across OK — which companies pay providers there.
